Antidepressant

Applications rac-trans-N-Desmethyl Sertraline-d3 Hydrochloride is deuterium labelled rac-trans-N-Desmethyl Sertraline Hydrochloride (D292117), which is a metabolite of Sertraline. rac-trans-N-Desmethyl Sertraline-d3 Hydrochloride can be used for treating CNS disorders. References Welch, W.M., et al.: J. Med. Chem. 27, 1508 (1984)

Applications 7-Cl-kynurenic acid (7-Cl-KYNA) is a potent, selective antagonist of the NMDA/glycine receptor but penetrates poorly through the blood-brain barrier.  Its prodrug, L-4-Cl-kynurenine (4-Cl-KYN), readily enters the brain from the circulation and provides antiexcitotoxic neuroprotection after systemic application. References Leeson, P., et al.: J. Med. Chem., 37, 4053 (1994), Hilmas, C., et al.: J. Neurosci., 2001, 21, 7463 (2001), Palmer, G., et al.: Curr. Drug Targets, 2, 241 (2001), Wu, H., et al.: Exp. Neurol., 177, 222 (2002),

Applications Labelled Viloxazine (V312440). Antidepressant. References Howe, R., et al.: J. Med. Chem., 19, 1074 (1976), Pinder, R.M., et al.: Drugs, 13, 401 (1977),

Applications (S,S) Enantiomer metabolite of Bupropion (B689625), an antidepressant. References Hsyu, P-H., et al.: J. Clin. Pharm., 37, 737 (1997), Rotzinger, S., et al.: Cellular & Mol. Neurobiology, 19, 4, 427 (1999); US 6342496

Moclobemide (Ro111163) is a reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.

Applications N-Nitro-α-[2-(Methylamino)ethyl]benzyl Alcohol is a derivative of α-[2-(Methylamino)ethyl]benzyl Alcohol(M286120); an impurity of fluoxetine (F597100). References Tarkhanova, I.G. et al.: Russ. Chem. Bull., 55, 1624 (2006); Tarkhanova, I.G. et al.: Kin. Catal., 48, 711 (2007);

Stability Moisture Sensitive Applications Fluvoxamine impurity. References Wieling, J., et al.: J. Chromatogr., 635, 195 (1993), Hilhorst, M., et al.: J. Pharm. Biomed. Anal., 16, 1251 (1998),

Impurity Mirtazapine Applications A labelled metabolite of Mirtazapine, α2-adrenergic blocker. References De Boer, T., et al.: Neuropharmacology, 27, 399 (1988), Smith, W.T., et al.: Psychopharmacol. Bull., 26, 191 (1990)

Impurity Fluvoxamine EP impurity B Applications The geometric isomer of the second-generation antidepressant Fluvoxamine. References Palego, L., et al.: Ther. Drug Monit., 22, 190 (2000), Miolo, G., et al.: Eur. J. Pharmacol., 450, 223 (2002), Hostetter, A., et al.: Ther. Drug Monit., 26, 47 ( 2004), Stahl, S., et al.: Curr. Med. Chem., 11, 313 (2004), Kwon, J., et al.: J. Pharmaceut. Biomed., 37, 643 (2005)

Applications The major metabolite of Fluvoxamine. References Overmars, H., et al.: Eur. J. Drug Metab. Pharmacokinet., 8, 269 (1983), Benfield, P., et al.: Drugs, 32, 313 (1986), Perucca, E., et al.: Clin. Pharmacokinet., 27, 175 (1994), Jerling, M., et al.: Br. J. Clin. Pharmacol., 44, 447 (1997),

Applications Labelled Nefazodone (N389100). A selective serotonin 5-HT2 receptor antagonist. A novel antidepressant that shows no cardiac toxicity or anticholinergic activity common with tricyclic antidepressants. References Eison, A.S., et al.: Psychopharmacol. Bull., 26, 311 (1990), Keller, M.B., et al.: N. Engl. J. Med., 342, 1462 (2000)

Applications An α2-Adrenergic blocker; analogue of Mianserin. Antidepressant. References De Boer, T., et al.: Neuropharmacology, 27, 399 (1988), Smith, W.T., et al.: Psychopharmacol. Bull., 26, 191 (1990)

Applications 5-Allylidene-10,11-dihydro-5H-dibenzo[a,d][7]annulene is an impurity of Nortriptyline (N837000) and Amitriptyline (A552600), both of which are antidepressant. References Hale, J. L., et al.: Anal. Profiles Drug Subs., 1, 233 (1972); Rubin, E.H., et al.: J. Clin. Psychiatry, 46, 418 (1985); Blessel, K.W., et al.: Anal. Profiles Drug Subs., 3, 127 (1974); Tobe, A., et al.: Arzneim.-Forsch., 31, 1278 (1981)

Applications Antidepressant; serotonin transport blocker that also blocks norepinephrine uptake. References Longosch, et al.: Eur. Neuropsychopharmacol., 8, 209 (1998), Chouinard, et al.: Cell. Mol. Neurobiol., 19, 533 (1999), Plenge-Tellechea, et al.: Arch. Biochem. Biophys., 370, 119 (1999),